Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

127.43
Delayed Data
As of Jul 31
 +1.97 / +1.57%
Today’s Change
52.35
Today|||52-Week Range
140.00
+31.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues82.8M66.7M47.2M50.6M
 
 
 
 
 
Depreciation And Amortization5.1M9.0M10.2M11.9M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses132.5M121.3M129.9M222.8M
 
 
 
 
 
Research And Development99.3M86.6M113.0M190.2M
 
 
 
 
 
Total Operating Expenses137.6M130.3M140.1M234.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-54.8M-63.6M-92.9M-184.2M
 
 
 
 
 
Extraordinary Charge-500.0K-65.9M0.00-220.8M
 
 
 
 
Pre-Tax Equity Earnings-3.5M-4.5M0.000.00
 
 
 
Other Expenses-31.0K16.4M-47.0K1.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-57.6M-116.6M-91.9M-400.6M
 
 
 
 
 
Income Taxes0.00-10.6M-2.7M-40.2M
 
 
 
 
Net Income-57.6M-106.0M-89.2M-360.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.4M50.3M61.6M74.3M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M50.3M61.6M74.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.36-$2.11-$1.45-$4.85
 
 
 
 
 
EPS Diluted-$1.36-$2.11-$1.45-$4.85